Home » Pierre Fabre Drug Fails to Win NICE Backing for Bladder Cancer
Pierre Fabre Drug Fails to Win NICE Backing for Bladder Cancer
Pierre Fabre SA had its medicine Javlor rejected by the UK’s health-cost agency to treat bladder cancer in patients who have undergone prior treatment.
Bloomberg
Bloomberg
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May